Conclusion Oral GLP1 therapy for type 2 diabetes could change how we approach diabetes management
Kurtzberg J, Asselin B, Bernstein M, Buchanan GR, Pollock BH, Camitta BM
Your provider will individualize this based on your tolerance, side effect history, and how much weight you still want to lose
Hubo tres fases que se desarrollaron en 26 semanas: dosis iniciales, aumento de la medicacin y dosis de mantenimiento
HS can worsen with obesity because HS symptoms typically appears in areas prone to friction such as the underarms, groin, and under the breasts
While there is some animal data and limited human research supporting its potential use case, its safety and efficacy profile is still not well-understood